Back to Trades
Chambers Rebecca
Chief Financial OfficerCIK 0001823563
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 7
- Companies
- 2
- Active
- 2025–2026
Across 9 filings between 2025–2026, Chambers Rebecca, Chief Financial Officer, has disclosed $5.1M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.7M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Jun 4 | VCYT VERACYTE, INC. | Chambers Rebecca | Chief Financial Officer | Sell | $177.1K |
| Apr 20 | ALMR Alamar Biosciences, Inc. | Chambers Rebecca | Insider | Other | $2.1M |
| Apr 16 | ALMR Alamar Biosciences, Inc. | Chambers Rebecca | Insider | Other | $0 |
| Mar 6 | VCYT VERACYTE, INC. | Chambers Rebecca | Chief Financial Officer | Sell | $662.9K |
| Mar 4 | VCYT VERACYTE, INC. | Chambers Rebecca | Chief Financial Officer | Tax withheld | $260.5K |
| Mar 2 | VCYT VERACYTE, INC. | Chambers Rebecca | Chief Financial Officer | Grant | $466.9K |
| Dec 4 | VCYT VERACYTE, INC. | Chambers Rebecca | Chief Financial Officer | Sell | $622.0K |
| Nov 7 | VCYT VERACYTE, INC. | Chambers Rebecca | Chief Financial Officer | Sell | $287.0K |
| Sep 4 | VCYT VERACYTE, INC. | Chambers Rebecca | Chief Financial Officer | Tax withheld | $161.7K |
9 filings